These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7857163)

  • 1. [New achievements in the fluoroquinolone problem: possibilities of increasing activity and expansion of the spectrum of action].
    Padeĭskaia EN
    Antibiot Khimioter; 1994 May; 39(5):52-65. PubMed ID: 7857163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gaps and perspectives of new fluoroquinolones.
    Neuman M; Esanu A
    Drugs Exp Clin Res; 1988; 14(6):385-91. PubMed ID: 3215107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent updates of fluoroquinolones as antibacterial agents.
    Ezelarab HAA; Abbas SH; Hassan HA; Abuo-Rahma GEA
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800141. PubMed ID: 30048015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756).
    Hayashi K; Takahata M; Kawamura Y; Todo Y
    Arzneimittelforschung; 2002; 52(12):903-13. PubMed ID: 12572531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
    Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
    J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lipophilicity at N-1 on activity of fluoroquinolones against mycobacteria.
    Renau TE; Sanchez JP; Shapiro MA; Dever JA; Gracheck SJ; Domagala JM
    J Med Chem; 1995 Jul; 38(15):2974-7. PubMed ID: 7636859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M; Coll R; Esteve M; Parés J; Xicota MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones.
    Coll R; Gargallo-Viola D; Tudela E; Xicota MA; Llovera S; Guinea J
    Antimicrob Agents Chemother; 1996 Jan; 40(1):274-7. PubMed ID: 8787924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity and synthetic metodologies for the preparation of fluoroquinolones, a class of potent antibacterial agents.
    Da Silva AD; De Almeida MV; De Souza MV; Couri MR
    Curr Med Chem; 2003 Jan; 10(1):21-39. PubMed ID: 12570719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluoroquinolones, 10 years later].
    de la Blanchardière A; Carbon C
    Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects.
    Gootz TD; Brighty KE
    Med Res Rev; 1996 Sep; 16(5):433-86. PubMed ID: 8865150
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluoroquinolones: mechanism of action, classification, and development of resistance.
    Blondeau JM
    Surv Ophthalmol; 2004 Mar; 49 Suppl 2():S73-8. PubMed ID: 15028482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on antibacterial and antifungal agents. XI. New antibacterial quinolones related to pirfloxacin.
    Massa S; Corelli F; Mai A; Artico M; Panico S; Simonetti N
    Farmaco; 1989 Sep; 44(9):779-93. PubMed ID: 2604833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
    Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of fluoroquinolones against gram-positive bacteria.
    Bush K; Goldschmidt R
    Curr Opin Investig Drugs; 2000 Sep; 1(1):22-30. PubMed ID: 11249591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitutions of amino acids in alpha-helix-4 of gyrase A confer fluoroquinolone resistance on Clostridium perfringens.
    Rafii F; Park M
    Arch Microbiol; 2007 Feb; 187(2):137-44. PubMed ID: 17051403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines.
    Dang Z; Yang Y; Ji R; Zhang S
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4523-6. PubMed ID: 17566733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.